Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy
Authors:
- Krzysztof KaczmarekKKKrzysztof Kaczmarek
- Iwona CygankiewiczICIwona Cygankiewicz
- Witold StrebWSWitold Streb
- Rafal PlaksejRPRafal Plaksej
- Piotr JakubowskiPJPiotr Jakubowski
- Zbigniew KalarusZKZbigniew Kalarus
- Pawel PtaszynskiPawel Ptaszynski
- Jerzy Krzysztof WraniczJWJerzy Krzysztof Wranicz
- Anna Babicz-SadowskaABAnna Babicz-Sadowska
- Agata MarkiewiczAMAgata Markiewicz
- Marek GrygierMGMarek Grygier
Open Access
- 12 February 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (4) , 726
Abstract
We analyzed clinical experience with percutaneous closure of instances of left atrial appendage with thrombus (LAAT) irresponsive to antithrombotic therapy in patients treated in three high-volume cardiology centers. Clinical and procedural data regarding consecutive patients who underwent percutaneous left atrial appendage closure (PLAAC) due to LAAT were retrospectively analyzed. The study population consisted of 17 patients (11 men; 68 ± 14 years; CHA2DS2VASC 4.7 ± 1.9; HASBLED 3 (0–5)) with LAAT confirmed by transesophageal echocardiography, and included 5 patients with mechanical heart valves. Most of the patients (94.1%) received anticoagulation therapy before PLAAC. All LAATs were located in distal portions of the appendage and occupied less than 30% of its volume. Occluding-device implantation was successful in 17 patients; in one, a residual leak was disclosed. Appropriate positioning of occluders required more than 1 attempt in 6 individuals (35.3%); in 3 others (17.6%), the subjects’ devices had contact with thrombi. No procedural complications were noted. Midterm follow-up (median: 10 months) revealed no procedure-related complications or clinically diagnosed thromboembolism. Transesophageal echocardiography (TEE) performed after six months revealed device-related thrombus in one patient. We concluded that LAAT irresponsive to antithrombotic therapy might be effectively treated with PLAAC, even in patients with mechanical-valve prostheses.Keywords
This publication has 25 references indexed in Scilit:
- Percutaneous left atrial appendage closure in the presence of thrombus: A feasibility reportJournal of Cardiovascular Electrophysiology, 2019
- EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an updateEP Europace, 2019
- ISOLATED SURGICAL LEFT ATRIAL APPENDAGE EXCISION FOR STROKE PREVENTION IN THE ERA OF PERCUTANEOUS THERAPYJACC, 2019
- Left Atrial or Left Atrial Appendage Thrombus Resolution After Adjustment of Oral Anticoagulant TreatmentJournal of Stroke and Cerebrovascular Diseases, 2019
- Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral AnticoagulationThe American Journal of Cardiology, 2019
- Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacyEuroIntervention, 2018
- Left atrial appendage closure in a patient with left atrial appendage thrombus using a novel fish ball techniqueInternational Journal of Cardiology, 2017
- Locked AwayCirculation: Arrhythmia and Electrophysiology, 2016
- Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)American Heart Journal, 2016
- Self-Expandable Device for Percutaneous Closing of Left Atrial Appendage With Organized Thrombus in a Patient With Permanent Atrial FibrillationCanadian Journal of Cardiology, 2013